← Back to Search

Procedure

Sacrocolpopexy + Posterior Repair for Prolapse-Related Bowel Symptoms

N/A
Waitlist Available
Led By Lieschen Quiroz, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Posterior vaginal bulge ≤2cm beyond the hymen
Female Gender
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months postoperative
Awards & highlights

Study Summary

This trial found that patients who had both laparoscopic sacrocolpopexy and posterior repair had better bowel symptom scores at 3 months post-op than those who only had laparoscopic sacrocolpopexy.

Who is the study for?
This trial is for women who can fill out English questionnaires and attend study visits for 6 months. They should have a posterior vaginal bulge ≤2cm beyond the hymen with bowel symptoms (PFDI-O score ≥3). It's not for those under 21, pregnant, with past colorectal surgery or pelvic radiation, inflammatory bowel disease, or previous sacrocolpopexy.Check my eligibility
What is being tested?
The study is testing if adding a posterior repair to laparoscopic sacrocolpopexy improves bowel symptoms in women with uterine or vaginal prolapse better than just the sacrocolpopexy alone after three months.See study design
What are the potential side effects?
Possible side effects may include discomfort at the surgical site, infection risk from surgery, bleeding complications, and potential issues related to general anesthesia used during procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vaginal bulge extends 2cm or less beyond the hymen.
Select...
I am female.
Select...
I experience significant bowel symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
(obstructed defecation symptoms)
Secondary outcome measures
(correlation between bowel symptoms scores and 3D ultrasound measurements)

Trial Design

2Treatment groups
Active Control
Group I: LSCP OnlyActive Control1 Intervention
A Y-shaped polypropylene mesh graft, 10 cm in standard length and tailored to each patient's anatomic specifications during surgery, is used utilizing robot-assisted Laparoscopic Sacrocolopopexy.
Group II: LSCP + PRActive Control2 Interventions
The Laparoscopic Sacrocolopopexy involves a Y-shaped polypropylene mesh graft, 10 cm in standard length and tailored to each patient's anatomic specifications during surgery, utilizing robot-assisted Laparoscopic Sacrocolopopexy. In addition, patients will receive posterior repair. Posterior repair is performed by midline fascial plication. Plication of superficial perineal muscles (perineorrhaphy) is performed in conjunction with posterior repair. All repairs are performed using polydioxanone 2/0 for fascial repair and 4/0 polyglactin suture for skin closure.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,550 Total Patients Enrolled
Lieschen Quiroz, MDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
313 Total Patients Enrolled
Edgar L LeClaire, MD, MSPrincipal InvestigatorUniversity of Oklahoma

Media Library

Laparoscopic Sacrocolopopexy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03658395 — N/A
Vaginal Prolapse Research Study Groups: LSCP Only, LSCP + PR
Vaginal Prolapse Clinical Trial 2023: Laparoscopic Sacrocolopopexy Highlights & Side Effects. Trial Name: NCT03658395 — N/A
Laparoscopic Sacrocolopopexy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03658395 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment actively recruiting participants?

"This particular trial, which was first shared on July 19th 2018 and last modified on October 5th 2022 is not currently accepting candidates. However, there are 78 other trials actively recruiting patients at this time according to information available on clinicaltrials.gov."

Answered by AI

Is eligibility for this research limited to persons of a certain age range?

"As specified in the guidelines for this trial, eligible subjects must fall within a certain age range; 21 years of age at minimum and 80 years old at maximum."

Answered by AI

Am I eligible to join the clinical experiment?

"This research is seeking 60 people with a diagnosis of vaginal prolapse, aged between 21 and 80. The most important conditions for participation include: Female Gender, Ability to understand English language questionnaires, Capacity to attend follow-up visits over 6 months, A PFDI-O score of at least 3 points and Posterior vaginal bulge that does not exceed 2cm beyond the hymen."

Answered by AI
~5 spots leftby Nov 2024